Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Single-Cell RNA-Seq Analysis Uncovers Distinct Functional Human NKT Cell Sub-Populations in Peripheral Blood

Frontiers in Cell and Developmental Biology(2020)10.3389/fcell.2020.00384Source: DataRank Database

Single-Cell RNA-Seq Analysis Uncovers Distinct Functional Human NKT Cell Sub-Populations in Peripheral Blood is a research paper published in Frontiers in Cell and Developmental Biology (2020). On theSindex it has a DataRank of 0. It has been cited 49 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access49 citations

Download PDF

Cite:

Linked data & code

geo

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)OA: goldTopics (12)Linked Datasets (14)DataCite Reuse (14)IDs (PubMed, PMC)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Indra Adrianto ORCID,Jie Wang ORCID,Xiaojun Wu,Indrani Datta ORCID,Qing‐Sheng Mi ORCID

Live enrichment

PubMed:32528956 PMC:PMC7264113

National Institutes of Health

Grant: 1R01AI119041-01

National Institutes of Health

Grant: 1R56AI119041-01

microRNAs and NKT cell development and function

Henry Ford Health System

Grant: T71017

Henry Ford Health System

Grant: T71016

NIAID NIH HHS

Grant: R01 AI119041

NIAMS NIH HHS

Grant: R01 AR063611

NIAID NIH HHS

Grant: R56 AI119041

National Institutes of Health

Grant: 2R01AR063611-06A1

Genetic and Genomic Dissection of Psoriatic Arthritis

goldLicense: cc-by

publisherhttps://doi.org/10.3389/fcell.2020.00384

publisherhttps://www.frontiersin.org/article/10.3389/fcell.2020.00384/full

repositoryhttps://doaj.org/article/ec381cd837dd42ec97b40a1d880ef350

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7264113

Unpaywallhttps://www.frontiersin.org/articles/10.3389/fcell.2020.00384/pdf

Fields of Study

0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

Natural killer T cellsGene express profileSingle Cell Rna SequencingCell Survival And ProliferationPeripheral Blood Mononucleotide CellsCell Population AnalysisCell and Developmental BiologyQH301-705.5Biology (General)

Sustainable Development Goals

SDG 3: 3. Good health

Additional file 1 of Increased Tc17 cell levels and imbalance of naïve/effector immune response in Parkinson’s disease patients in a two-year follow-up: a case control study

10.6084/m9.figshare.16575416.v1figshare

Additional file 1 of Increased Tc17 cell levels and imbalance of naïve/effector immune response in Parkinson’s disease patients in a two-year follow-up: a case control study

10.6084/m9.figshare.16575416figshare

Additional file 2 of Increased Tc17 cell levels and imbalance of naïve/effector immune response in Parkinson’s disease patients in a two-year follow-up: a case control study

10.6084/m9.figshare.16575419figshare

Additional file 2 of Increased Tc17 cell levels and imbalance of naïve/effector immune response in Parkinson’s disease patients in a two-year follow-up: a case control study

10.6084/m9.figshare.16575419.v1figshare

Additional file 3 of Increased Tc17 cell levels and imbalance of naïve/effector immune response in Parkinson’s disease patients in a two-year follow-up: a case control study

10.6084/m9.figshare.16575422.v1figshare

Additional file 3 of Increased Tc17 cell levels and imbalance of naïve/effector immune response in Parkinson’s disease patients in a two-year follow-up: a case control study

10.6084/m9.figshare.16575422figshare

Additional file 4 of Increased Tc17 cell levels and imbalance of naïve/effector immune response in Parkinson’s disease patients in a two-year follow-up: a case control study

10.6084/m9.figshare.16575428.v1figshare

Additional file 4 of Increased Tc17 cell levels and imbalance of naïve/effector immune response in Parkinson’s disease patients in a two-year follow-up: a case control study

10.6084/m9.figshare.16575428figshare

Additional file 5 of Increased Tc17 cell levels and imbalance of naïve/effector immune response in Parkinson’s disease patients in a two-year follow-up: a case control study

10.6084/m9.figshare.16575431.v1figshare

Additional file 5 of Increased Tc17 cell levels and imbalance of naïve/effector immune response in Parkinson’s disease patients in a two-year follow-up: a case control study

10.6084/m9.figshare.16575431figshare

Additional file 6 of Increased Tc17 cell levels and imbalance of naïve/effector immune response in Parkinson’s disease patients in a two-year follow-up: a case control study

10.6084/m9.figshare.16575434.v1figshare

Additional file 6 of Increased Tc17 cell levels and imbalance of naïve/effector immune response in Parkinson’s disease patients in a two-year follow-up: a case control study

10.6084/m9.figshare.16575434figshare

Additional file 7 of Increased Tc17 cell levels and imbalance of naïve/effector immune response in Parkinson’s disease patients in a two-year follow-up: a case control study

10.6084/m9.figshare.16575437.v1figshare

Additional file 7 of Increased Tc17 cell levels and imbalance of naïve/effector immune response in Parkinson’s disease patients in a two-year follow-up: a case control study

10.6084/m9.figshare.16575437figshare